Shares of Relx PLC (LON:REL) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1,875.42 and traded as high as $1,881.74. Relx shares last traded at $1,845.00, with a volume of 2,393,794 shares trading hands.
Several equities analysts have recently issued reports on REL shares. Citigroup reissued a “neutral” rating and issued a GBX 1,880 ($24.57) price objective on shares of Relx in a report on Wednesday, August 14th. Berenberg Bank decreased their price objective on Relx from GBX 1,950 ($25.48) to GBX 1,930 ($25.22) and set a “buy” rating for the company in a report on Friday, October 25th. JPMorgan Chase & Co. boosted their price objective on Relx from GBX 1,900 ($24.83) to GBX 1,950 ($25.48) and gave the company an “overweight” rating in a report on Friday, July 26th. Liberum Capital reissued a “buy” rating and issued a GBX 1,750 ($22.87) price objective on shares of Relx in a report on Thursday, October 24th. Finally, Deutsche Bank reissued a “hold” rating on shares of Relx in a report on Friday, July 26th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of GBX 1,891.92 ($24.72).
The firm has a market cap of $36.29 billion and a price-to-earnings ratio of 23.90. The company has a fifty day moving average price of GBX 1,834.73 and a 200-day moving average price of GBX 1,876.17. The company has a current ratio of 0.45, a quick ratio of 0.40 and a debt-to-equity ratio of 308.02.
Relx Company Profile (LON:REL)
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
Recommended Story: Why is the LIBOR significant?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.